* EC: The recommended dosage is 20 mg orally once daily in combination with pembrolizumab 200 mg administered as an intravenous infusion over 30 minutes every 3 weeks.
* RCC: The recommended dosage is: * 20 mg orally once daily with pembrolizumab 200 mg administered as an intravenous infusion over 30 minutes every 3 weeks.
* 18 mg orally once daily with everolimus 5 mg orally once daily.
Modify the recommended daily dose for certain patients with renal or hepatic impairment.
biomarker testing
Lenvima clinical details
Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.
Benefits investigations are conducted to determine whether a therapy is covered under a patient's insurance, if a prior authorization is required, and which specialty pharmacies are preferred.
Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance
How to sign up
Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned
Patient benefit
Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted
Patient eligibility
Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.
How to sign up
Patients submit proof of out-of-pocket drug costs to charities for reimbursement
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Learn More
Other resources brands publish to help support patients and caregivers.
Other resources
Learn More
Other resources brands publish to help support patients.
people also ask
Lenvima FAQs
How is the dosage of Lenvima?Lenvima is available in 9 dosages, including 4 mg Cap, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack and mixed Pack
What does Lenvima treat?Lenvima treats Renal Cell Carcinoma and Thyroid Neoplasms
What is Lenvima made of?Lenvima contains lenvatinib which is a Kinase Inhibitor
How Is Lenvima Administered?Lenvima is administered as a Oral Pill or Pack
What Are The Lenvima Mechanism Of Action?Lenvima mechanism of action is Receptor Tyrosine Kinase Inhibitors
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available